XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -11.46%544.81M | -19.38%573.13M | -7.74%676.75M | 5.98%1.12B | 18.39%615.34M | -12.28%710.88M | -5.71%733.51M | 5.30%1.06B | -34.99%519.75M | -35.34%810.38M |
Notes receivable and accounts receivable | -16.79%1.29B | 14.52%1.77B | -6.82%1.58B | -10.71%1.33B | -10.09%1.54B | -15.42%1.54B | -6.08%1.7B | -6.88%1.49B | 19.89%1.72B | 12.80%1.82B |
-Notes receivable | 50.48%70.37M | 2.19%70.99M | -27.60%61.68M | 31.57%87.82M | -39.46%46.77M | -17.18%69.46M | -21.09%85.2M | -43.05%66.75M | 54.97%77.25M | 65.29%83.87M |
-Accounts receivable | -18.89%1.22B | 15.10%1.69B | -5.72%1.52B | -12.70%1.24B | -8.71%1.5B | -15.34%1.47B | -5.13%1.61B | -4.02%1.42B | 18.63%1.64B | 11.10%1.74B |
Other receivables (including interest and dividends) | 7.06%88.59M | -13.52%81.42M | -5.82%95.19M | -19.37%75.58M | -25.58%82.75M | -14.32%94.15M | 17.87%101.07M | -14.69%93.74M | -26.61%111.19M | -42.66%109.89M |
-Other receivable | ---- | -13.52%81.42M | ---- | ---- | ---- | -14.32%94.15M | ---- | -4.00%93.74M | ---- | -42.66%109.89M |
Contractual assets | -7.56%349.62M | -19.01%352.8M | -8.71%371.08M | -8.63%354.76M | -15.28%378.19M | 9.87%435.63M | 2.42%406.5M | -10.99%388.27M | 0.30%446.4M | -0.19%396.48M |
Advance payment | 98.48%75.28M | 186.12%92.64M | 32.24%40.91M | -4.33%31.29M | -27.22%37.93M | -15.51%32.38M | -33.86%30.94M | -27.74%32.71M | 31.68%52.11M | -31.64%38.32M |
Inventories | -16.92%1.07B | -16.94%989.11M | -4.83%906.81M | -3.38%810.17M | 11.99%1.29B | 11.83%1.19B | 9.68%952.79M | 9.92%838.53M | 31.38%1.15B | 30.76%1.06B |
Other current assets | -89.61%20.02M | -86.55%15.41M | -79.45%54.46M | -64.26%100.68M | -56.26%192.62M | -52.80%114.57M | -34.28%265.03M | -35.58%281.68M | 251.31%440.36M | 69.56%242.72M |
Total current assets | -17.05%3.43B | -6.07%3.87B | -10.99%3.73B | -8.59%3.82B | -6.73%4.14B | -8.14%4.12B | -4.55%4.19B | -4.86%4.18B | 6.54%4.44B | 0.31%4.49B |
Non Current assets | ||||||||||
Other equity investment | 0.66%168.59M | 0.90%168.99M | 0.00%167.49M | 0.00%167.49M | 0.00%167.49M | 1,553.59%167.49M | 1,553.59%167.49M | 1,553.59%167.49M | -60.01%167.49M | -97.60%10.13M |
Other non-current financial assets | 0.00%99.06M | 0.00%99.06M | 0.00%99.06M | 0.00%99.06M | 0.00%99.06M | -56.58%99.06M | -56.58%99.06M | -71.09%99.06M | --99.06M | --228.13M |
Long-term equity investment | 28.81%438.7M | 30.23%445.51M | 27.54%367.32M | 27.67%370.74M | 23.57%340.59M | 22.72%342.1M | 6.37%288.01M | 7.62%290.4M | 45.69%275.62M | 103.08%278.77M |
Fixed assets | ---- | 7.19%503.31M | ---- | ---- | ---- | 0.14%469.55M | ---- | 1.86%474.57M | ---- | 29.10%468.9M |
Constru in process | ---- | 34.44%289.9M | ---- | ---- | ---- | 27.48%215.63M | ---- | 32.15%190.93M | ---- | 84.63%169.15M |
Intangible assets | 18.00%1.66B | 20.56%1.74B | 27.21%1.82B | 2.40%1.4B | 2.20%1.4B | 2.78%1.44B | 22.08%1.43B | 10.75%1.36B | 19.02%1.37B | 14.40%1.4B |
Development expenditure | -51.16%278.64M | -59.86%208.11M | -73.84%122.83M | 9.99%585.32M | 14.43%570.47M | 21.14%518.4M | -23.20%469.49M | -2.32%532.13M | -18.63%498.53M | -15.65%427.93M |
Goodwill | -47.61%266.65M | -47.61%266.65M | -50.72%266.65M | -50.72%266.65M | -39.11%508.94M | -39.11%508.94M | -35.27%541.07M | -42.17%541.07M | -11.06%835.86M | -11.06%835.86M |
Long deferred expense | -13.78%14.28M | -13.54%14.57M | -15.90%14.9M | -10.67%16M | -7.02%16.56M | -3.16%16.85M | 1.66%17.72M | 0.18%17.91M | -2.19%17.81M | -13.78%17.4M |
Deferred tax assets | 82.45%323.93M | 80.22%315.79M | 94.38%293.52M | 74.98%262.28M | 77.56%177.54M | 82.34%175.23M | 114.92%151M | 103.25%149.89M | 160.36%99.99M | 129.41%96.1M |
Usufruct assets | 6.01%16.89M | -19.63%13.85M | -16.91%15.06M | -26.80%14.94M | -22.20%15.93M | -22.44%17.24M | 0.07%18.13M | -12.30%20.41M | 74.78%20.48M | 61.98%22.23M |
Other non current assets | 47,984.21%104.46M | -21.62%216.24K | 12,575.79%47.12M | -83.91%7.56M | -92.14%217.24K | -96.92%275.88K | -98.09%371.73K | -73.66%47.01M | -98.44%2.77M | -94.92%8.96M |
Total non current assets | 6.54%4.22B | 2.30%4.06B | 0.91%3.95B | -0.16%3.89B | -3.57%3.96B | 0.16%3.97B | 1.68%3.92B | -8.10%3.89B | 2.35%4.11B | 0.68%3.97B |
Total assets | -5.51%7.65B | -1.96%7.93B | -5.24%7.68B | -4.52%7.71B | -5.21%8.1B | -4.25%8.09B | -1.64%8.1B | -6.45%8.08B | 4.48%8.54B | 0.48%8.45B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 59.43%654.42M | 35.33%633.26M | 38.80%566.26M | 36.82%535.8M | -24.42%410.48M | -16.46%467.95M | 0.65%407.98M | -29.18%391.61M | -13.64%543.14M | -14.10%560.16M |
Notes payable and accounts payable | 82.19%127.09M | 740.86%462.46M | 16.04%125.3M | 49.39%185.28M | -19.63%69.76M | -46.21%55M | -7.18%107.98M | -51.79%124.03M | -17.37%86.8M | -9.09%102.25M |
-Notes payable | 1,355.75%33.22M | 9,751.79%351.34M | -58.80%19.02M | -64.24%4.99M | 91.75%2.28M | -84.58%3.57M | 15.26%46.16M | -87.53%13.96M | -93.62%1.19M | -54.29%23.13M |
-Accounts payable | 39.12%93.87M | 116.04%111.12M | 71.92%106.28M | 63.80%180.29M | -21.18%67.47M | -35.00%51.43M | -18.97%61.82M | -24.26%110.07M | -0.91%85.61M | 27.88%79.13M |
Contract liabilities | -34.03%221.86M | -42.51%178.75M | 22.91%351.63M | -12.50%188.85M | 45.15%336.33M | 77.76%310.92M | 88.19%286.09M | 29.93%215.82M | 489.46%231.71M | 37.91%174.91M |
Salaries payable | 208.00%60.04M | 9.09%63.14M | 5.62%63.69M | -6.22%61.53M | 3.39%19.49M | 189.98%57.88M | 183.48%60.3M | 1.55%65.62M | 35.86%18.85M | 10.36%19.96M |
Taxs payable | -7.81%29.83M | 9.18%27.31M | -17.81%20.29M | -9.53%37.91M | 8.61%32.36M | -4.94%25.01M | -11.85%24.69M | -7.16%41.9M | -4.18%29.8M | -28.76%26.31M |
Other payable (including interest and dividends) | 9.96%22.71M | -55.68%21.13M | -61.06%25.73M | 3.77%42.12M | -3.13%20.65M | 104.87%47.68M | 1,310.33%66.08M | -16.35%40.59M | -32.12%21.32M | -40.30%23.27M |
-Other payable | ---- | -55.68%21.13M | ---- | ---- | ---- | 104.87%47.68M | ---- | -16.35%40.59M | ---- | -32.93%23.27M |
Non current liabilities due within one year | 84.75%20.27M | 8.49%15.87M | 82.22%16.93M | -93.69%20.53M | -96.47%10.97M | -95.34%14.63M | -9.00%9.29M | 2,913.44%325.14M | --310.46M | 528.55%314.27M |
Other current liabilities | -6.03%31.06M | -10.85%39.52M | -32.13%32.23M | 18.25%54.77M | -24.49%33.05M | 51.82%44.33M | 9.96%47.49M | 11.55%46.32M | 92.10%43.77M | 13.76%29.2M |
Total current liabilities | 25.10%1.17B | 40.85%1.44B | 19.03%1.2B | -9.93%1.13B | -27.43%933.09M | -18.15%1.02B | 29.29%1.01B | 5.40%1.25B | 47.39%1.29B | 17.84%1.25B |
Current liabilities | ||||||||||
Long term loan | -13.81%323.56M | -4.18%322.98M | -9.78%310.29M | 152.00%306.97M | 440.08%375.41M | 384.94%337.08M | 394.76%343.91M | 75.03%121.82M | 107.43%69.51M | 15.85%69.51M |
Deferred tax liabilities | 28.62%39.32M | 13.83%38.92M | 30.13%44.78M | -14.27%31.87M | -10.98%30.57M | -1.38%34.19M | 52.24%34.42M | 85.07%37.17M | 198.93%34.34M | 218.87%34.67M |
Long term deferred income | -50.57%65.16M | -29.46%79.38M | -29.60%79.47M | -2.81%108.81M | 14.43%131.83M | 4.38%112.53M | 19.24%112.88M | -6.49%111.96M | 5.50%115.2M | 2.68%107.82M |
Lease liabilities | 2.26%10.25M | -9.22%10.13M | -3.76%10.26M | -12.87%8.31M | -29.65%10.02M | -8.62%11.16M | -7.01%10.67M | -24.07%9.54M | 10.96%14.24M | -9.25%12.22M |
Total non current liabilities | -20.00%438.3M | -8.80%451.42M | -11.37%444.8M | 62.56%455.96M | 134.82%547.84M | 120.76%494.97M | 0.88%501.87M | -47.26%280.49M | -49.90%233.3M | -54.06%224.21M |
Total liabilities | 8.42%1.61B | 24.66%1.89B | 8.94%1.65B | 3.35%1.58B | -2.51%1.48B | 2.97%1.52B | 18.24%1.51B | -10.89%1.53B | 13.53%1.52B | -4.81%1.47B |
Shareholders equity | ||||||||||
Paid-in capital | -1.18%1.14B | 0.00%1.15B | 0.00%1.15B | 0.00%1.15B | 0.00%1.15B | 0.00%1.15B | 0.00%1.15B | 0.00%1.15B | -0.46%1.15B | -0.46%1.15B |
Capital reserve funds | -3.08%2.74B | -0.02%2.82B | -0.02%2.82B | -0.02%2.82B | -0.11%2.83B | -0.11%2.83B | -0.11%2.83B | -0.11%2.83B | -1.17%2.83B | -1.62%2.83B |
Surplus reserve funds | 0.00%192.84M | -0.00%192.83M | -0.00%192.83M | 0.00%192.83M | 0.00%192.83M | 0.00%192.83M | 0.00%192.83M | -0.00%192.83M | 6.06%192.83M | 7.14%192.83M |
Retained profit | -19.48%1.97B | -18.31%1.96B | -18.01%1.95B | -16.58%1.94B | -12.82%2.44B | -12.81%2.4B | -13.04%2.38B | -13.42%2.33B | 8.37%2.8B | 9.58%2.75B |
Less:Treasury stock | ---- | --100M | --100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | -8.71%6.04B | -8.21%6.03B | -8.08%6.02B | -5.95%6.11B | -5.19%6.61B | -5.14%6.57B | -5.21%6.55B | -5.26%6.5B | 2.82%6.97B | 3.02%6.92B |
Minority interests | 102.22%9.66M | 129.95%11.61M | -71.59%12.35M | -69.53%12.92M | -90.37%4.78M | -90.34%5.05M | -15.90%43.48M | -16.70%42.42M | -10.61%49.58M | -62.73%52.28M |
Total shareholder equity | -8.63%6.05B | -8.11%6.04B | -8.49%6.03B | -6.36%6.13B | -5.80%6.62B | -5.77%6.57B | -5.29%6.59B | -5.35%6.54B | 2.71%7.02B | 1.68%6.98B |
Total liabilityies and equity | -5.51%7.65B | -1.96%7.93B | -5.24%7.68B | -4.52%7.71B | -5.21%8.1B | -4.25%8.09B | -1.64%8.1B | -6.45%8.08B | 4.48%8.54B | 0.48%8.45B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.